Condition: Vasodilatory Shock · Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A randomized, double-blind, placebo-controlled study on the treatment of refractory distributed shock with angiotensin II injection, with a random ratio of 1:1. Assuming a success rate of 25% for the main therapeutic endpoint in the control group and 50% for the experimental group, a total of 214 subjects will be enrolled, including 107 in the experimental group and 107 in the control group.
This description comes directly from the study's public registry record.
Xiangdong Guan, M.D. · 13802925067 · guanxiangdong1962@163.com
Yan Kang, M.D. · 13808041931 · kangyan_hx@163.com
Always discuss trial participation with your own doctor first.
| The Second People's Hospital of Hefei | Hefei, Anhui, China | Not Yet Recruiting |
| The Frist Affiliated Hospital of Wannan Medical College | Wuhu, Anhui, China | Not Yet Recruiting |
| Beijing Tiantan Hospital,Capital Medical University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The Frist Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| The people's Hospital of the University of traditional Chinese medicine in Fujian | Fuzhou, Fujian, China | Not Yet Recruiting |
| Gansu Provincial Hospital | Lanzhou, Gansu, China | Not Yet Recruiting |
| The First Affiliated Hospital of Sun Yat sen University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Zhujiang Hospital of Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The First Affiliated Hospital of Jinan University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Qingyuan Hospital Affiliated to Guangzhou Medical University | Qingyuan, Guangdong, China | Not Yet Recruiting |
| The First Affiliated Hospital of Shantou University Medical College | Shantou, Guangdong, China | Not Yet Recruiting |
+ 30 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06351150